| Application no. and date | 19842679.3 (espacenet) (Federated) (European Patent Register), 20191219 | | Patent/reg. no. and date | DK/EP 3897672, 20230809 | | Publication date | 20211027 | | Priority no. and date | US 201862782896 P, 20181220 | | EP pub. no. and date |
EP 3897672 20211027 | | Effective date | | | Applicant/owner | Humabs Biomed SA, Via dei Gaggini, 3
6500 Bellinzona, CH,
Vir Biotechnology, Inc., 1800 Owens Street
Suite 900
San Francisco, CA 94158, US | | Applicant ref. no. | 166376 | | Inventor | CORTI, Davide, c/o Humabs BioMed SA
Via dei Gaggini 3
6500 Bellinzona, CH,
BAKARDJIEV, Anna, c/o Vir Biotechnology, Inc. 499 Illinois, Suite
500
San Francisco, California 94158, US,
PANG, Phillip S., c/o Vir Biotechnology, Inc. 499 Illinois, Suite
500
San Francisco, California 94158, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/713 (2006.01) , A61K 39/42 (2006.01) , A61P 31/20 (2006.01) | | Title | HBV KOMBINATIONSBEHANDLING | | Int. application no. | US2019067643 | | Int. publication no. | WO2020132346 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
